311 related articles for article (PubMed ID: 33671639)
1. Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis.
Thavamani A; Salem I; Sferra TJ; Sankararaman S
Metabolites; 2021 Feb; 11(2):. PubMed ID: 33671639
[TBL] [Abstract][Full Text] [Related]
2. The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis.
Karb DB; Cummings LC
Curr Gastroenterol Rep; 2021 Aug; 23(10):17. PubMed ID: 34448955
[TBL] [Abstract][Full Text] [Related]
3. Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.
Madan JC
Clin Ther; 2016 Apr; 38(4):740-6. PubMed ID: 26973296
[TBL] [Abstract][Full Text] [Related]
4. What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?
van Dorst JM; Tam RY; Ooi CY
Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276841
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions.
Tam RY; van Dorst JM; McKay I; Coffey M; Ooi CY
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160099
[TBL] [Abstract][Full Text] [Related]
6. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.
Bertolini A; Nguyen M; Zehra SA; Taleb SA; Bauer-Pisani T; Palm N; Strazzabosco M; Fiorotto R
J Hepatol; 2024 Mar; ():. PubMed ID: 38554847
[TBL] [Abstract][Full Text] [Related]
7. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
8. An
Barrack KE; Hampton TH; Valls RA; Surve SV; Gardner TB; Sanville JL; Madan JL; O'Toole GA
J Bacteriol; 2024 Jan; 206(1):e0028623. PubMed ID: 38169295
[TBL] [Abstract][Full Text] [Related]
9. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.
Caley LR; White H; de Goffau MC; Floto RA; Parkhill J; Marsland B; Peckham DG
Dig Dis Sci; 2023 May; 68(5):1797-1814. PubMed ID: 36600119
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
11. CFTR dysregulation drives active selection of the gut microbiome.
Meeker SM; Mears KS; Sangwan N; Brittnacher MJ; Weiss EJ; Treuting PM; Tolley N; Pope CE; Hager KR; Vo AT; Paik J; Frevert CW; Hayden HS; Hoffman LR; Miller SI; Hajjar AM
PLoS Pathog; 2020 Jan; 16(1):e1008251. PubMed ID: 31961914
[TBL] [Abstract][Full Text] [Related]
12. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
Ooi CY; Syed SA; Rossi L; Garg M; Needham B; Avolio J; Young K; Surette MG; Gonska T
Sci Rep; 2018 Dec; 8(1):17834. PubMed ID: 30546102
[TBL] [Abstract][Full Text] [Related]
13. Probiotic supplementation in children with cystic fibrosis-a systematic review.
Ananthan A; Balasubramanian H; Rao S; Patole S
Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
[TBL] [Abstract][Full Text] [Related]
14. Probiotics Administration in Cystic Fibrosis: What Is the Evidence?
Esposito S; Testa I; Mariotti Zani E; Cunico D; Torelli L; Grandinetti R; Fainardi V; Pisi G; Principi N
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956335
[TBL] [Abstract][Full Text] [Related]
15. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis.
Nielsen S; Needham B; Leach ST; Day AS; Jaffe A; Thomas T; Ooi CY
Sci Rep; 2016 May; 6():24857. PubMed ID: 27143104
[TBL] [Abstract][Full Text] [Related]
16. The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.
Garg M; Ooi CY
Curr Gastroenterol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155088
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
[TBL] [Abstract][Full Text] [Related]
18. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis: evidence for gut inflammation.
Munck A
Int J Biochem Cell Biol; 2014 Jul; 52():180-3. PubMed ID: 24548777
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota in adults with cystic fibrosis: Implications for the severity of the CFTR gene mutation and nutritional status.
Durda-Masny M; Goździk-Spychalska J; Morańska K; Pawłowska N; Mazurkiewicz M; Skrzypczak I; Cofta S; Szwed A
J Cyst Fibros; 2024 Jul; ():. PubMed ID: 38960841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
